C-terminal human IgG Fc domain fusion (referred to as Spike-RBD) was prepared as
previously described50 (link). Calu-3 cells
were grown in 96-well flat bottom plates until >50% confluent. Media was aspirated
and cells were washed once with PBS. Cells were then treated with TrypLE to release them
from the plate, RPMI 1640 media was added to dilute TrypLE, and cells were pelleted by
centrifugation at 200×g for five minutes. From this point on, all steps were
carried out on ice. Cells were incubated in 3% BSA (Sigma Aldrich A7030) in DPBS
(Sigma-Aldrich D8537) for 15 minutes to block and washed twice in 3% BSA in DPBS by
centrifugation at 200×g for five minutes in v-bottom plates, followed by
resuspension. Spike-RBD was diluted in 3% BSA to appropriate concentrations and incubated
with cells for 30 minutes on ice. Cells were then washed twice with 3% BSA in DPBS and
incubated with Anti-Strep PE-Cy7 (Thermofisher SA1012) at 5 μg/mL. Cells were
washed twice and subjected to flow cytometry on a FACS Celesta in HTS mode. Cells were
gated to exclude doublets and the median PE-Cy7 signal was calculated for each sample. The
gating strategy is shown in
Figure 2
calculated by fitting the RBD binding data into a Sigmoidal, 4PL model in Prism 6.